Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

A study on prescribing patterns of antihypertensives in geriatric patients.

Mohd AH, Mateti UV, Konuru V, Parmar MY, Kunduru BR.

Perspect Clin Res. 2012 Oct;3(4):139-42. doi: 10.4103/2229-3485.103595.

PMID:
23293761
[PubMed]
Free PMC Article
2.

Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.

Pareek A, Chandurkar NB, Sharma R, Tiwari D, Gupta BS.

Clin Drug Investig. 2010;30(2):123-31. doi: 10.2165/11531770-000000000-00000.

PMID:
20067330
[PubMed - indexed for MEDLINE]
3.

Impact of therapy initiation with amlodipine or losartan on hemodynamic endpoints and JNC-VI blood pressure stage.

Putnam D, Griffis D, McLaughlin TP, Arocho R, Tang S.

Am J Ther. 2006 Mar-Apr;13(2):94-100.

PMID:
16645423
[PubMed - indexed for MEDLINE]
4.

Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.

Shimosawa T, Gohchi K, Yatomi Y, Fujita T.

Hypertens Res. 2007 Sep;30(9):831-7.

PMID:
18037776
[PubMed - indexed for MEDLINE]
5.

Antihypertensive drug prescription trends at the primary health care centres in Bahrain.

Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.

Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27.

PMID:
11501335
[PubMed - indexed for MEDLINE]
6.

Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women.

Tandon VR, Sharma S, Mahajan S, Mahajan A, Khajuria V, Mahajan V, Prakash C.

J Midlife Health. 2014 Apr;5(2):78-83. doi: 10.4103/0976-7800.133994.

PMID:
24970986
[PubMed]
Free PMC Article
7.
8.

Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.

Am J Hypertens. 2007 Mar;20(3):311-8.

PMID:
17324745
[PubMed - indexed for MEDLINE]
9.

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.

Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T; Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.

Clin Exp Nephrol. 2003 Sep;7(3):221-30.

PMID:
14586719
[PubMed - indexed for MEDLINE]
11.

Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.

de la Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, de la Figuera M, Garcia-Garcia M, Falkon L; CENIT Study Working Group.

Clin Drug Investig. 2009;29(7):459-69. doi: 10.2165/00044011-200929070-00004.

PMID:
19499963
[PubMed - indexed for MEDLINE]
12.

Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.

Suzuki H, Shimada Y, Fujiwara K.

Ther Adv Cardiovasc Dis. 2012 Dec;6(6):237-44. doi: 10.1177/1753944712464285. Epub 2012 Nov 5.

PMID:
23129531
[PubMed - indexed for MEDLINE]
13.

Amlodipine/ARB fixed-dose combinations for the treatment of hypertension: focus on amlodipine/olmesartan combination.

Chrysant SG.

Drugs Today (Barc). 2008 Jun;44(6):443-53. doi: 10.1358/dot.2008.44.6.1219543. Review.

PMID:
18596998
[PubMed - indexed for MEDLINE]
14.

Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.

Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Shin DG, Jeong JW, Yoon JH, Park SH, Kwon J, Cho SY.

Clin Ther. 2011 Dec;33(12):1953-63. doi: 10.1016/j.clinthera.2011.11.007. Epub 2011 Dec 2. Erratum in: Clin Ther. 2012 Aug;34(8):1844. Jung, Jin Won [corrected to Jeong, Jin Won].

PMID:
22136978
[PubMed - indexed for MEDLINE]
15.

Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K; OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group.

Am J Med. 2012 Oct;125(10):981-90. doi: 10.1016/j.amjmed.2011.12.010. Epub 2012 Apr 14.

PMID:
22503610
[PubMed - indexed for MEDLINE]
17.
18.

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.

Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.

Blood Press. 2004;13(3):137-41.

PMID:
15223721
[PubMed - indexed for MEDLINE]
19.

Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.

Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.

Curr Med Res Opin. 2003;19(3):226-37.

PMID:
12803737
[PubMed - indexed for MEDLINE]
20.

Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective observational study.

Meno H, Inou T, Tanaka M, Tsuchiya Y, Shiga Y, Kobayashi K, Nakamura Y, Ota T, Kubara I.

Clin Drug Investig. 2012 Mar 1;32(3):171-8. doi: 10.2165/11597620-000000000-00000.

PMID:
22188593
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk